Abstract
Introduction

39
DNA double-strand breaks (DSBs) are cytotoxic lesions that can lead to chromosomal breaks, mers (k = n + m) (e.g. a pentamer can fall apart to form a monomer and a tetramer, or a dimer and 143 a trimer). This model provides the concentrations of RAD51 polymers in solution, and is solved in 144 the steady-state so that it only depends on a single fit parameter K D (i.e. the RAD51 promoter-145 promoter dissociation constant). The predicted concentrations are then inserted into the kinetic 146 models to describe RAD51 polymerisation on ssDNA and dsDNA.
148
The next two kinetic models described the sequential formation of RAD51 polymers on ssDNA and 149 on dsDNA. We tested models of increasing complexity based on mass action kinetics until we 150 identified models that were able to fit the experimental datasets (see Supplementary Information 151 for details). Both the ssDNA and dsDNA models allow for the adsorption of any RAD51 n-mer from 152 solution onto DNA (provided at least n DNA binding sites are available), given that n-mers (1 ≤ n ≤ 153 16) can exist in solution. Polymer elongation occurs when a RAD51 m-mer in solution binds to a 154 DNA-bound n-mer to form a DNA-bound (n+m)-mer, provided that at least n + m DNA binding sites 155 are available and 1 < m + n ≤ 16. However, unbinding was assumed to only take place via single 156 protomer dissociation and via the dissociation of short RAD51 nuclei. This is a valid assumption for dsDNA includes k p , k u , and k s , but without the need for k q to describe dissociation of quasi-167 stable nuclei (i.e. 2 RAD51 molecules) (Fig. 1C) . For dsDNA, k u describes the rate of dissociation 168 of RAD51 monomers not bound to a RAD51 polymer (Fig. 2B) .
170
Using ABC-SMC to fit these models to the ssDNA dN-X data (Fig. 1B) and the dsDNA dN-Xp data
171
( Fig. 1D) , values for the model parameters were determined ( Fig. 2 A and B, S2 ). This analysis 172 identified a nano-molar range RAD51 protomer-protomer dissociation constant (dN-X and dN-Xp K D = 1.14 ± 0.5 nM) as a key factor driving rapid RAD51 polymerisation on both ssDNA and 174 dsDNA, similarly to other studies using either pressure perturbation fluorescence spectroscopy 175 (Schay et al., 2016) or single molecule fluorescence microscopy (Candelli et al., 2014) . This is due 176 to the fact that this K D value enables WT RAD51 to form abundant long polymers in solution at 
182
Importantly, we also identified a 6.5-fold higher ssDNA polymerisation forward rate constant (dN-X k p = (2.6 ± 1.8) × 10 -2 /µM/s) compared to dsDNA (dN-Xp k p = (4 ± 0.6) × 10 -3 /µM/s), explaining the 184 overall faster RAD51 polymerisation on ssDNA ( Fig. 2 A and B) . Overall, these analyses suggest
185
that WT RAD51 adsorption and/or elongation is faster on ssDNA compared to dsDNA, and that a 186 high protomer-protomer affinity enables WT RAD51 to nucleate and elongate effectively on ssDNA
187
and dsDNA even at low concentrations of RAD51.
189
RAD51 polymerises faster on flexible DNA
190
Overall, our analyses suggest that WT RAD51 can nucleate more efficiently on short dsDNA 191 molecules but polymerises significantly faster on long ssDNA molecules. We speculate that the difference in RAD51 polymerisation speed is due to the higher flexibility of ssDNA compared to dsDNA. Explicitly, we propose a Bend-To-Capture (BTC) mechanism to explain how DNA flexibility
194
can impact polymerisation kinetics (Fig. 3A) . 
202
To test this notion, we designed an experiment to measure the kinetics of WT RAD51 binding to
203
DNA oligos of varying flexibility. It has been shown that poly-dT ssDNA, which is widely used for
204
RAD51 binding assays, is highly flexible, while poly-dA ssDNA is highly rigid due to base stacking
205
interactions (Mills et al., 1999 ) (Sim et al., 2012 . Consistently, our SAXS-derived persistence
206
length measurements showed ssDNA dT-50 is the most flexible oligo, followed by dN-50, dA-50
207
and dsDNA dN-50p ( Fig. S3 and Table 1 ). By measuring RAD51 binding kinetics to these DNA 208 oligos ( Fig. 3B) , we found that WT RAD51 indeed displayed faster association to the dT-50 209 compared to the dN-50, and the model fit suggests this is due to a higher polymerisation rate 210 constant (k p ) ( Fig. 3 C and D) . Furthermore, WT RAD51 displayed very slow association to the dA-211 50, comparable to that of dsDNA dN-50p, which is explained by a lower polymerisation rate 212 constant ( Fig. 3 C and D) . Conversely, individually fitting the unstable reverse rate constant (k u ),
213
the quasi-stable reverse rate constant (k q ) or the stable reverse rate constant (k s ) cannot explain 214 the ssDNA dT-50 or dA-50 data ( Fig. S4 A-C contribution, RAD51 will exhibit faster unbinding from flexible DNA compared to stiff DNA, as this is 242 consistent with both reduced RAD51 binding at equilibrium and faster binding due to the Bent-to-To directly test this hypothesis, we assessed the kinetics of a RAD51 mutant, which confers a reduced enthalpic contribution compared to WT RAD51. We predicted that, with such a mutation,
247
the stability of the mutant RAD51 polymers on DNA would become more dependent on the 248 flexibility of the underlying DNA (Fig. 4 A and B) . We took advantage of a phenylalanine to glutamate substitution at RAD51 residue 86 (F86E), which reduces the RAD51 protomer-protomer 250 interaction affinity (Pellegrini et al., 2002; Esashi et al., 2007; Yu et al., 2003) . Indeed, using size-
251
exclusion chromatography with multi-angle light scattering (SEC-MALS), we confirmed that F86E
252
RAD51 is primarily monomeric in solution ( Fig. S5 A-C) . We then used SPR to measure the 253 binding kinetics of F86E RAD51 to ssDNA dT-50, dN-50, dA-50 and dsDNA dN-50p, and used
254
ABC-SMC to fit a simplified polymerisation model simultaneously to all four data sets (Fig. 4D) .
the F86E RAD51 binding kinetics to the short ssDNA oligos (dN-5, dN-8, dN-11, dN-14, dN-17) 
257
and dsDNA oligos (dN-5p, dN-8p, dN-11p) were not systematically measured due to low F86E 258 purification yield. It was immediately evident that F86E RAD51 shows significantly reduced affinity
259
for ssDNA and dsDNA compared to WT RAD51, with no detectable binding to DNA at the 260 concentration of 150 nM or 3 µM (Fig. S5 D and E) . Nonetheless, at 30 µM, we observed F86E
261
RAD51 displays faster elongation on more flexible DNA (Fig. 4 B and E, Fig. S6 ), as we observed
262
for WT RAD51 (Fig. 3 C and D) . Additionally, DNA-binding at 30 µM can be explained by the fact (Fig. 4 F and G) . This is in contrast to WT RAD51 (K D
265
= 1.14 ± 0.5 nM), which can form abundant, long polymers in solution at 150 nM or 3 µM [WT
266
RAD51] (Fig. 2 C and D) . Strikingly, F86E RAD51 displayed reduced lifetimes (1/k pr ) that inversely 267 correlated with the flexibility of DNA (Fig. 4H) 
281
RAD51 binding per unit time (the BTC mechanism) (Fig. 3A) , and 2) the enthalpic contribution of
282
RAD51 polymerisation enables RAD51 to overcome the entropic penalty to binding to flexible DNA
283
(the EPC mechanism) (Fig. 4A) .
285
The diploid human genome consists of 6.4 billion base pairs and ~ 50 endogenous DSBs are 286 estimated to occur in every cell cycle (Vilenchik and Knudson, 2003) . In human cells, the resection 
299
It is important to note that resected ssDNA is first bound by RPA prior to RAD51 polymerisation.
300
RPA is a heterotrimer complex with six-OB folds, four of which can associate tightly with ssDNA in 301 a stepwise manner (Fan and Pavletich, 2012; Zou et al., 2006 
339
has been demonstrated in mammalian cells (Aten et al., 2004; Cho et al., 2014; Aymard et al., 340 2017) . Hence, this work presents a conceptual advancement in linking DNA repair and DNA 341 flexibility, adding an important dimension which should be taken account of when assessing repair 342 process both in biochemical assays and in cellular contexts.
344
Material and methods
345
RAD51 Mutagenesis
346
The bacterial expression vector pET11d (Merck-Millipore) carrying the human WT RAD51 (WT-GCTAAATTAGTTCCAATGGGTGAGACC ACTGCAACTGAATTCCACC -3' and a reverse primer pET11d were grown in LB media containing 100 µg/ml ampicillin and 25 µg/ml chloroamphenicol,
355
and by adding 0.5 mM IPTG at OD 595 = 0.6, protein expression was induced. Cell pellets were 356 resuspended in PBS and mixed with the equal volume of lysis buffer (3 M NaCl, 100 mM Tris-HCl 357 pH 7.5, 4 mM EDTA pH 8, 20 mM ß-mercaptoethanol, Sigma Protease Inhibitor Cocktail (Sigma)).
358
The suspension was sonicated and spun at 20k rpm with a 45 Ti rotor (Beckman). The supernatant 
369
RAD51 purification was carried out by chromatography at 4°C using the AKTA Pure Protein
370
Purification System (GE Healthcare). For WT RAD51, the dialysed WT RAD51 containing sample 371 was loaded onto a 5 ml HiTrap Heparin column (GE Healthcare) and eluted via a linear gradient of 372 200 mM -600 mM KCl. The peak fractions were pooled and dialysed in TEG200, and 373 concentrated on a 1 ml HiTrap Q column (GE Healthcare) followed by the isocratic elusion with fractionated through a 5 ml HiTrap Heparin column, but with a linear gradient of 75 mM -600 mM
378
KCl. The flow-through and F86E RAD51 peak fractions were pooled and dialysed in TEG buffer 379 containing 50 mM KCl (TEG50) and reloaded onto a 5 ml HiTrap Heparin column. Following a 50 380 mM -600 mM KCl linear gradient elution, F86E RAD51 peak fractions were pooled and dialysed in 381 TEG buffer containing 100 mM KCl (TEG100). The sample was concentrated on a 1 ml HiTrap Q 382 column followed by TEG600 isocratic elution. Peak fractions were applied on a 24 ml Superdex200 aliquoted, snap frozen and stored at -80°C.
388
Multi-Angle Light Scattering
389
To confirm the monomeric status of F86E RAD51, the peak size-exclusion chromatography F86E
390
RAD51 elution fraction was serially diluted (5, 1:1 serial dilutions) and loaded onto a Superdex200 DNA / RNA synthesizer using a standard 1.0 µmole phosphoramidite cycle of acid-catalyzed
The flexibilities of the ssDNA dT-50, ssDNA dN-50, ssDNA dA-50 and the dsDNA dN-50p (Shodex). 50 µl of DNA sample was injected and elution was carried out at 37°C at 75 µl/min using 434 SPR running buffer in the absence of glycerol and BSA. The flexible cylinder model was fit to the 435 four scattering data sets within the 0.0037 -0.27 [1/Å] range to derive the persistence lengths.
436
Data plotting and fitting was carried out using the SasView software for SAXS data analysis.
438
Surface Plasmon Resonance
439
The binding kinetics of WT and F86E RAD51 on ssDNA and dsDNA were assessed via surface 440 plasmon resonance (SPR) using a Biacore T200 (GE Healthcare). CM5 SPR chip flow cells were 
448
Chip activation and ligand immobilisation steps were carried out at 25°C. Using high performance 449 injections, the CM5 chip surfaces were then primed via 10 injections of 10 µl SPR running buffer
450
(150 mM KCl, 20 mM Hepes pH 7.5, 2 mM DTT, 5 mg/ml BSA, 2.5 mM ATP pH 7.5, 10 mM CaCl 2 ,
SPR Data Processing
SPR traces were processed using the BIAEvaluation software (GE Healthcare) as following. First, 
492
The kinetic sub-models describe the formation of RAD51 polymers on DNA. Importantly, during 
503
X k p , k q , k s , and dN-Xp k p are well determined. dN-X k u and dN-Xp k u were undetermined, due to 504 the fact that 1) no RAD51 binding was observed to the dN-8 and dN-5p oligos, and 2) the for the dsDNA stable reverse rate constant (dN-Xp k s < 10 -3 ). . For F86E RAD51, ABC-SMC was 508 carried out in MATLAB 2016b to determine a unique set of parameters for the equilibrium sub-509 model and a simplified version of the kinetic sub-model (Fig. 4D) 
670
ABC-SMC probability densities for the simultaneous WT RAD51 ssDNA ( Fig. 2A ) and dsDNA 671 model (Fig. 2B ) fits of the ssDNA dN-X (Fig. 1B) and dsDNA dN-Xp (Fig. 1D ) SPR data. Heat 
680
10 -4 < dN-X k p < 10 4 , 10 -6 < dN-X k u < 10 3 , 10 -6 < dN-X k q < 10 3 , 10 -6 < dN-X k s < 10 3 , 10 -4 < dN-Xp k p < 10 4 , 10 -6 < dN-Xp k u < 10 3 , 10 -6 < dN-Xp k s < 10 3 . PD: probability density. dA-50 k pr < 10 3 , 10 -6 < dN-50p k p < 10 4 , 10 -6 < dN-50p k pr < 10 3 . PD: probability density. 
= 1.14 ± 0.5 nM ...
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